identifeye HEALTH, a medical diagnostics company at the forefront of AI and automation, today announced that it has been named to the 2025 New York Digital Health 100 (DH100), a recognition that highlights the most exciting and innovative startups in New York. Digital Health New York (DHNY) publishes the annual list in conjunction with the New York Healthcare Innovation Report 2025 which analyzes the digital health sector's investment trends, challenges, and opportunities.
“This recognition is a testament to both our achievements and the important work ahead as we bring identifeye HEALTH’s innovative solutions to market,” said Vicky Demas, CEO of identifeye HEALTH. “Millions of patients at risk for preventable conditions, like diabetic retinopathy, lack access to critical screenings. We are committed to closing this gap by empowering healthcare providers with AI-driven tools that make diagnostic care more accessible, efficient, and impactful.”
“Now in its sixth year, the New York DH100 has evolved and grown, and in that time, the digital health ecosystem in New York has also reached unprecedented levels of innovation and impact,” said Bunny Ellerin, co-founder and CEO, DHNY. “We are honored to celebrate these organizations, whose dedication to transformation and progress is driving the future of healthcare.”
Introduced in late 2024, identifeye HEALTH’s flagship product, the identifeye Camera, is transforming diagnostic care by making advanced retinal imaging more accessible in primary care settings. By automating complex processes such as patient alignment and image capture, the system requires minimal training, allowing healthcare professionals like medical assistants and general practitioners to seamlessly integrate retinal screenings into their workflow. As the identifeye Camera is integrated into healthcare settings, the company’s goal is to establish the retina as a key non-invasive diagnostic platform by using its system to detect neurological and cardiovascular diseases early.
To download a copy of the New York Healthcare Innovation Report, please click here.
For more information about identifeye HEALTH, visit identifeye.health.
About identifeye HEALTH
identifeye HEALTH is dedicated to making retinal imaging accessible and equitable through its intuitive, consumer-friendly platform that utilizes advanced AI and automation. By bringing care closer to patients, identifeye HEALTH aims to enhance efficiency and improve patient outcomes. The company’s investors include Foresite Capital, Glenview Capital Management, Hildred, and more.
About Digital Health New York (DHNY)
Digital Health New York (DHNY) is a connected community of digital health leaders who share ideas, spark new directions and create success across the entire ecosystem. As an organization, we seek to increase the visibility of New York City as a leader in healthcare innovation and showcase the companies and leaders creating the future of healthcare. Our flagship event, DHNY Summit, brings together an elite group of entrepreneurs, investors, payers, providers and executives to cultivate the New York digital health community and drive impactful conversations around the current and future state of digital health. DHNY was founded in 2022 in collaboration with AlleyCorp. For more information or to join DHNY’s mailing list, please visit www.dhny.co.
DH100 Methodology
To compile the DH100, we invited companies to complete an in-depth application with both quantitative and qualitative measures to help us to get to know the company better. We also used our dynamic database of digital health companies in the region to round out the consideration set. A company qualified for consideration if it maintained headquarters or employed at least 5 people in the New York region. Companies that were public or non-profit; founded before 2014; or had an exit were excluded. We evaluated companies on a number of factors, including but not limited to: strength of application, leadership, number of employees, funding, revenue, market fit, differentiated offerings, and community engagement.